Catalyst Wire Dossier Catalyst Wire Dossier

Epirubicine

epirubicin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epirubicine, covering 2009-05-29 to 2009-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Phase 3]

See pricing